Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inogen (INGN) Short term Debt (2013 - 2016)

Inogen (INGN) reported Short term Debt of $80000.0 for Q3 2016, down 74.28% year-over-year from $311000.0 in Q4 2015, and down 49.69% on a QoQ basis from $159000.0 in Q2 2016.

Inogen (INGN) has 4 years of Short term Debt data on file, last reported at $80000.0 in Q3 2016.

  • Quarterly Short term Debt fell 74.28% year-over-year to $80000.0 in Q3 2016, while the trailing twelve-month figure through Sep 2016 was $80000.0 (down 74.28% YoY) and the FY2015 annual result came in at $315000.0, up 5.35% from the prior year.
  • Short term Debt fell to $80000.0 in Q3 2016 per INGN's latest filing, from $159000.0 in the prior quarter.
  • Across five years, Short term Debt topped out at $7.1 million in Q2 2014 and bottomed at $80000.0 in Q3 2016.
  • The 4-year median for Short term Debt is $305000.0 (2015), against an average of $1.6 million.
  • Peak annual rise in Short term Debt reached 16.48% in 2015, while the deepest fall reached 95.66% in 2015.
  • Tracing INGN's Short term Debt over 4 years: stood at $5.3 million in 2013, then plunged by 94.31% to $299000.0 in 2014, then advanced by 5.35% to $315000.0 in 2015, then tumbled by 74.6% to $80000.0 in 2016.
  • Per Business Quant, the three latest INGN Short term Debt figures stand at $80000.0 (Q3 2016), $159000.0 (Q2 2016), and $238000.0 (Q1 2016).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Inogen 165.85 Mn 71.44 Mn 37.86 Mn

Historic Data

Download Data 🔒
DateValue
Sep 30, 2016 80,000.00
Jun 30, 2016 159,000.00
Mar 31, 2016 238,000.00
Dec 31, 2015 315,000.00
Sep 30, 2015 311,000.00
Jun 30, 2015 307,000.00
Mar 31, 2015 303,000.00
Dec 31, 2014 299,000.00
Sep 30, 2014 267,000.00
Jun 30, 2014 7.08 Mn
Mar 31, 2014 5.04 Mn
Dec 31, 2013 5.26 Mn